Skip to main content
Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
1.160
+0.090 (8.41%)
At close: Mar 9, 2026, 4:00 PM EDT
1.170
+0.010 (0.86%)
After-hours: Mar 9, 2026, 4:51 PM EDT

Hyperfine Revenue

Hyperfine had revenue of $3.44M in the quarter ending September 30, 2025, a decrease of -5.65%. This brings the company's revenue in the last twelve months to $10.59M, down -20.10% year-over-year. In the year 2024, Hyperfine had annual revenue of $12.89M with 16.84% growth.

Revenue (ttm)
$10.59M
Revenue Growth
-20.10%
P/S Ratio
10.55
Revenue / Employee
$95,414
Employees
111
Market Cap
112.72M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202412.89M1.86M16.84%
Dec 31, 202311.03M4.22M61.90%
Dec 31, 20226.81M5.32M355.48%
Dec 31, 20211.50M1.20M408.84%
Dec 31, 2020294.00K--
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Treace Medical Concepts 212.69M
Xtant Medical Holdings 133.08M
Neuronetics 129.87M
Pulmonx 90.50M
AVITA Medical 71.61M
LENSAR 59.14M
Apyx Medical 47.90M
MaxCyte 34.42M
Revenue Rankings

HYPR News

More News